This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Buy These 5 Low-Leverage Stocks Amid Waning Inflation Woes
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt. One may choose from OXM, ALK, LIN, PFBC and RNR to remain shielded in times of crisis.
RenaissanceRe (RNR) Up 7% on Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
RenaissanceRe's (RNR) fourth-quarter results reflect growing net premiums earned within the Property as well as Casualty and Specialty segments.
Best Value Stocks to Buy for February 1st
by Zacks Equity Research
ARCH and RNR made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 1, 2023.
RenaissanceRe (RNR) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of 11.40% and 1.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q4 Earnings on Jan 31: CB, UNM and RNR
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to aid fourth-quarter results of insurers like CB, UNM and RNR. However, an active catastrophe environment is likely to have weighed on insurers' performance.
2 Stocks to Consider Buying Before Earnings Next Week
by Shaun Pruitt
Both Mondelez International and RenassanceRe Holdings stock look intriguing going into their Q4 reports next week as rising earnings estimate revisions for FY23 are a good sign that these companies could offer positive guidance.
Analysts Estimate Hanover Insurance Group (THG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Hanover Insurance (THG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RenaissanceRe (RNR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
RenaissanceRe (RNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
Is it Time to Add Everest Re (RE) Stock to Your Portfolio?
by Zacks Equity Research
Segmental strength, a solid capital position and favorable growth estimates poise Everest Re (RE) well for growth.
RenaissanceRe (RNR) Up 19% in Past 6 Months: Further Upside Left?
by Zacks Equity Research
RenaissanceRe (RNR) is well-poised for growth due to improved premiums, solid segmental performances and robust operating cash flows.
RLI or RNR: Which P&C Stock is Better-Placed at the Moment?
by Zacks Equity Research
Let's see how RLI Corp. (RLI) and RenaissanceRe Holdings (RNR) fare in terms of some of the key metrics.
RenaissanceRe (RNR) Up 17.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RenaissanceRe (RNR) Rises 17.5% Despite Q3 Earnings Miss
by Zacks Equity Research
RenaissanceRe (RNR) repurchases shares worth $25.3 million in the reported quarter.
RenaissanceRe (RNR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of -24.93% and 13.51%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q3 Earnings on Nov 1: AIG, PRU and More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to aid third-quarter results of insurers like AIG, RNR, PRU, AIZ and UNM. However, an active catastrophe environment is likely to have weighed on insurers' performance.
Analysts Estimate Allstate (ALL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Allstate (ALL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will RenaissanceRe (RNR) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
RenaissanceRe (RNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Everest Re Group (RE) Unveils Q3 Catastrophe Loss Estimates
by Zacks Equity Research
Everest Re's (RE) third-quarter estimated cat loss of $730 million primarily takes into account losses from Hurricane Ian and other global catastrophe events.
Aegon (AEG) Sets Timeline for 3rd Tranche of Buyback Plan
by Zacks Equity Research
Aegon (AEG) announces the expected duration of the third tranche of its existing share buyback program. AEG also announces the closure of the program's second tranche on Sep 27.
RenaissanceRe (RNR) Stock Jumps 3.6%: Will It Continue to Soar?
by Zacks Equity Research
RenaissanceRe (RNR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RE or RNR: Which P&C Stock is Better-Placed at the Moment?
by Zacks Equity Research
Let's see how Everest Re (RE) and RenaissanceRe (RNR) fare in terms of some of the key metrics.
RenaissanceRe (RNR) Up 0.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RenaissanceRe (RNR) Stock Down 11% Despite Q2 Earnings Beat
by Zacks Equity Research
RenaissanceRe's (RNR) second-quarter results reflect rate increases and strong underwriting results at the Casualty and Specialty segment, partly offset by high expenses.
RenaissanceRe (RNR) Q2 Earnings Surpass Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of 9.11% and 2.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?